Abstract:
Infusion of antineoplastic medications in nontraditional settings, including the home, is not a new concept. However, the emergence of the novel coronavirus, COVID-19, has accelerated conversations around ensuring that patients with cancer can continue timely cancer treatment regimens while minimizing their risk of COVID-19 exposure and infection. Administration of antineoplastics through home infusion has been offered as a potential solution and continues to gain momentum among healthcare facilities and third-party payers.
Reference:Infusion of Antineoplastic Therapies in the Home. Oncol Nurs Forum. 2020 Nov 1;47(6):629-630. doi: 10.1188/20.ONF.629-630. PMID: 33063785.